Inside the research
Chemed Corporation
CHE Research profile · latest available data
Price overview
$512.16
▲ +16.51 (+3.3%)
| 52w hi | $551.99 |
|---|---|
| 52w lo | $367.60 |
| Vol | 233.30K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.66
| Short | +0.66 |
|---|---|
| Medium | +0.68 |
| Long | +0.63 |
computed 2026-09-27
Key fundamentals
Chemed Corporation
Healthcare · Medical Care Facilities
| Market cap | $6.69B |
|---|---|
| Enterprise value | $6.92B |
| Trailing P/E | 25.78x |
| Forward P/E | 18.61x |
| EV / EBITDA | 16.60x |
| P / S (ttm) | 2.58x |
| Profit margin | 10.6% |
| Return on equity | 27.1% |
| Revenue growth | +8.8% |
| Earnings growth | +43.7% |
| Debt / equity | 35.49 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.35 | |
| Sector | +0.08 | |
| Technical | +0.19 | |
| Earnings | +0.00 | |
| Sentiment | +0.53 |
macro × 1.00 · 2026-09-27
Business overview
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Risk Metrics
| Beta vs SPX | 0.22 |
|---|---|
| Corr SPX | 0.12 |
| Annual vol | 29.9% |
| Annual ret | -1.8% |
| Sharpe | -0.06 |
| Max DD | -40.5% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-28 | Earnings Release, Exhibits | read |
| 2026-05-19 | Shareholder Vote | read |
| 2026-04-23 | Earnings Release, Exhibits | read |
| 2026-04-13 | Material Agreement, Material Obligation… | read |
| 2026-02-25 | Earnings Release, Exhibits | read |
| 2025-10-28 | Earnings Release, Exhibits | read |
| 2025-07-29 | Earnings Release, Officer / Director Change… | read |
| 2025-06-27 | Reg FD Disclosure, Exhibits | read |
| 2025-05-20 | Shareholder Vote | read |
| 2025-04-23 | Earnings Release, Exhibits | read |
| 2025-02-26 | Earnings Release, Exhibits | read |
| 2024-10-29 | Earnings Release, Exhibits | read |
Dividends
| Yield (TTM) | 0.23% |
|---|---|
| $ / share (TTM) | $1.20 |
| 5y CAGR | +10.8% |
Annual dividend per share
| 2021 | $1.40 |
|---|---|
| 2022 | $1.48 |
| 2023 | $1.56 |
| 2024 | $1.80 |
| 2025 | $2.20 |
| 2026 | $0.60 |
SEC Filings
The Long Run
FY 2010–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.26B | +3.9% | |
| Operating income | $366.49M | +6.4% | |
| Net income | $265.24M | +8.2% | |
| Cash from ops | $388.27M | +14.7% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $503.12 | $514.51 | $498.79 | $512.16 | 233.30K |
| Sep 24 | $499.19 | $501.46 | $491.88 | $495.65 | 146.20K |
| Sep 23 | $494.97 | $505.22 | $493.98 | $498.09 | 138.50K |
| Sep 22 | $500.55 | $505.79 | $495.37 | $496.62 | 131.60K |
| Sep 21 | $507.79 | $509.59 | $496.97 | $499.62 | 159.30K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →